CBD Clinical Trial Results on Seizure Frequency in Dogs ‘Encouraging’

Atticus, a St. Bernard, gets a check-up as part of the CBD oil clinical trial at the James L. Voss Veterinary Teaching Hospital. He is pictured with Dr. McGrath and Breonna Thomas, clinical trials coordinator. Photo: John Eisele/CSU Photography

Promising, and exciting. Those are the words used by Dr. Stephanie McGrath to describe new findings from a trailblazing pilot study to assess the use of cannabidiol, or CBD, for dogs with epilepsy.

McGrath, a neurologist at Colorado State University’s James L. Voss Veterinary Teaching Hospital, led a small study with 16 pet dogs to assess the short-term effect of CBD on seizure frequency.

Based on her research, McGrath found that 89 percent of dogs who received CBD in the clinical trial had a reduction in the frequency of seizures. Nine dogs were treated with CBD, while seven dogs in a control group were treated with a placebo.

The research took place from 2016 to 2017, and results are published in the June 1 issue of the Journal of the American Veterinary Medical Association.

Be the first to comment

Leave a Reply

Your email address will not be published.




This site uses Akismet to reduce spam. Learn how your comment data is processed.